Background: Pulmonary hypertension (PH), recently redefined as mean pulmonary arterial
pressure> 20 mm Hg (PH20), may be observed in patients with atrial septal defects (ASD) …

Background—Pulmonary arterial hypertension (PAH) may develop in patients with atrial
septal defects (ASD); however, little is known about associated risk factors and its evolution …

Background Atrial septal defect (ASD) is a common form of congenital heart disease.
Significant shunts may increase the risk of developing pulmonary hypertension (PH). We …

Objectives: To examine the outcomes in patients with moderate or severe pulmonary arterial
hypertension (PAH) undergoing percutaneous atrial septal defect (ASD) closure. Design …

Pulmonary arterial hypertension (PAH) related to an atrial septal defect (ASD) poses a
challenge to transcatheter closure of an ASD. In patients with untreated ASDs, chronic …

We investigated the short-term and medium-term results in patients with pulmonary arterial
hypertension (PAH) associated with atrial septal defect (ASD) undergoing transcatheter …

Aims: This study aimed to provide a simple index for predicting the definitive indication for
transcatheter closure of atrial septal defect (ASD) with pulmonary arterial hypertension …

BACKGROUND: For patients with an atrial septal defect and pulmonary hypertension it can
be difficult to determine whether it is safe to intervene. With newer treatments for pulmonary …

Background The development or persistence of pulmonary arterial hypertension (PAH) after
atrial septal defect (ASD) closure at adult age is associated with a poor prognosis. The …

Pulmonary hypertension (PH), defined as mean pulmonary arterial pressure≥ 25 mm Hg,
may be a complication of a secundum atrial septal defect (ASD). This study sought to …